Design Therapeutics (NASDAQ: DSGN) net income
Design Therapeutics reported a net loss of $69.8m for fiscal 2025; in fiscal 2024 it reported a net loss of $49.6m. Earnings per share were −$1.22.
Design Therapeutics's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$69.8m | — | — | −$1.22 |
| 2024 | −$49.6m | — | — | −$0.88 |
| 2023 | −$66.9m | — | — | −$1.19 |
| 2022 | −$63.3m | — | — | −$1.14 |
| 2021 | −$35.5m | — | — | −$0.77 |
| 2020 | −$8.3m | — | −3,663.7% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Design Therapeutics net income compared with its sector
By net income for its latest fiscal year, Design Therapeutics ranks 295th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 293rd | ProKidney | −$69.0m | −7,725.2% |
| 294th | Senseonics | −$69.1m | −196.0% |
| 295th | Design Therapeutics | −$69.8m | — |
| 296th | Varex Imaging | −$70.3m | −8.3% |
| 297th | Sonida Senior Living | −$70.8m | −18.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Design Therapeutics
- How much did Design Therapeutics earn in fiscal 2025?
- Design Therapeutics reported a net loss of $69.8m for fiscal 2025. In fiscal 2024 it reported a net loss of $49.6m.
- What are the earnings per share of Design Therapeutics?
- They were −$1.22 in fiscal 2025, compared with −$0.88 in fiscal 2024.
- Where does Design Therapeutics rank in its sector by net income?
- It ranks 295th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Design Therapeutics come from?
- From the annual report (Form 10-K) that Design Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Design Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Design Therapeutics: the Design Therapeutics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.